2013 - ISODP 2013 Congress


Mini-Oral 1 on Donation

8.6 - Paediatric donation after cardiac death The story of Max

Presenter: Anne-Maree, Holmes, Nambour, Australia
Authors: Anne-Maree Holmes


Paediatric donation after cardiac death The story of Max

Anne-Maree Holmes1

1Nambour Hospital- Intensive care, Nambour Hospital/ Donatlife Queensland, Nambour, Australia

Donation after cardiac death the story of  Max

Only a small percentage of the organ donor pool is from the paediatric population approximately ten percent of donors were paediatric in 2010. Still in the early stages of the introduction of the Donation after Cardiac Death (DCD) process a 3yr old boy MAX was admitted with severe hypoxia to the Paediatric Intensive care unit with a grossly abnormal MRI and a GCS of 3. Overtime his parents were given a poor prognosis and unlikely survivability. Discussions moved to focus on withdrawal of life supporting therapies.

Max’s parents introduced the idea of organ and tissue donation. A perfusion scan showed limited perfusion to the brain .Donation form cardiac death would be the pathway to facilitate max becoming an organ donor.

The decision to follow the DCD pathway was easy as Max’s parents were highly motivated they wanted Max to be able to help other children and to prevent another family having to deal with the loss of a child.  Both the State medical director and the Director of Genetics were engaged where no reason was found for donation after cardiac death not to proceed.

With supportive enthusiastic staff we were able to proceed with the donation after cardiac death. Many staff had limited or no experience and sop were wary of the process ofDCD but with small education sessions and support from the donatelife staff everyone worked well and the donation was a success.

Max was extubated at 04:19 and death was declared at 04:27. Max donated both his kidneys to recipients who now 3 years later are doing well and his heart valves that were donated have also been used.


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi